Annual Drug Patent Expirations for VOSEVI
Vosevi is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are eighteen patents protecting this drug.
Drug patent litigation for VOSEVI.
This drug has two hundred and seventy-seven patent family members in forty-seven countries.
The generic ingredient in VOSEVI is sofosbuvir; velpatasvir; voxilaprevir. One supplier is listed for this compound. Additional details are available on the sofosbuvir; velpatasvir; voxilaprevir profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
